Invus Public Equities, L.P. 13D and 13G filings for Kalaris Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 1:21 pm Purchase | 2025-06-30 | 13G | Kalaris Therapeutics Inc KLRS | Invus Public Equities, L.P. | 282,586 1.500% | 282,586 (New Position) | Filing |